IDiyas

For the Inventor, By the Inventor

Encinitas, CA, United States of America

Yixing Shen

USPTO Granted Patents = 15


 

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • San Diego, CA (US) (2012 - 2013)
  • Encinitas, CA (US) (2010 - 2023)

Company Filing History:

goldMedal15 out of 134 
 
Ligand Pharmaceuticals, Inc.
 patents

Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 11773110 - Heterocycle amines and uses thereof (2023-10-03),
2. 11413274 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2022-08-16),
3. 11186593 - Heterocycle amines and uses thereof (2021-11-30),
4. 10736875 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2020-08-11),
5. 10604533 - Heterocycle amines and uses thereof (2020-03-31),
6. 10111859 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2018-10-30),
7. 10030034 - Heterocycle amines and uses thereof (2018-07-24),
8. 9622991 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2017-04-18),
9. 9492430 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor (2016-11-15),
10. 9266874 - Heterocycle amines and uses thereof (2016-02-23),
11. 9144557 - Hematopoietic growth factor mimetic small molecule compounds and their uses (2015-09-29),
12. 8680150 - Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors (2014-03-25),
13. 8580811 - Androgen receptor modulator methods (2013-11-12),
14. 8193357 - Androgen receptor modulator compounds (2012-06-05),
15. 7816372 - 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds (2010-10-19),

Title: Yixing Shen: Innovator in Chemistry and Medicine

Introduction

Yixing Shen is a prominent inventor based in Encinitas, California. He has made significant contributions to the fields of chemistry and medicine, holding a total of 15 patents. His work focuses on developing compounds and methods that address various medical challenges.

Latest Patents

Among his latest patents, Yixing Shen has developed heterocycle amines and their uses. These compounds and methods are particularly relevant in treating inflammatory disorders. Additionally, he has worked on methods and compositions associated with the granulocyte colony-stimulating factor receptor. Some of these embodiments include identifying compounds that modulate the activity of the receptor, which can be beneficial in treating hematopoietic or neurological disorders.

Career Highlights

Yixing Shen is currently employed at Ligand Pharmaceuticals, Inc., where he continues to innovate and contribute to the advancement of medical science. His extensive research and development efforts have positioned him as a key figure in his field.

Collaborations

Throughout his career, Yixing Shen has collaborated with notable colleagues, including Lin Zhi and Bijan Pedram. These partnerships have further enhanced his research and the impact of his inventions.

Conclusion

Yixing Shen's work exemplifies the intersection of innovation and practical application in medicine. His contributions through patents and collaborations continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…